Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter SARS-CoV-2 Spike Antikörper (RBD)

Dieser Anti-SARS-CoV-2 Spike-Antikörper ist ein Maus-Chimeric-Antikörper zum Nachweis von SARS-CoV-2 Spike in Neut. Geeignet für SARS Coronavirus-2 (SARS-CoV-2).
Produktnummer ABIN7271727
580,80 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 9 bis 10 Werktagen

Kurzübersicht für Rekombinanter SARS-CoV-2 Spike Antikörper (RBD) (ABIN7271727)

Target

Alle SARS-CoV-2 Spike (SARS-CoV-2 S) Antikörper anzeigen
SARS-CoV-2 Spike (SARS-CoV-2 S)

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 255
  • 7
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Wirt

  • 87
  • 86
  • 50
  • 26
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Maus

Klonalität

  • 219
  • 22
  • 16
Chimeric

Konjugat

  • 232
  • 11
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SARS-CoV-2 Spike Antikörper ist unkonjugiert

Applikation

  • 173
  • 35
  • 27
  • 13
  • 10
  • 10
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Neutralization (Neut)

Klon

AM122
  • Bindungsspezifität

    • 95
    • 7
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    RBD

    Verwendungszweck

    Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122)

    Spezifität

    This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain.

    Produktmerkmale

    Recombinant Antibodies produced in HEK293. Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein.

    Immunogen

    Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein. 

    Isotyp

    IgA
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    -20°C
  • Target

    SARS-CoV-2 Spike (SARS-CoV-2 S)

    Andere Bezeichnung

    SARS-CoV-2 Spike

    Substanzklasse

    Viral Protein

    Hintergrund

    It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Sie sind hier:
Chat with us!